Related Experiment Video

Updated: May 4, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
07:44

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

115

Translational research in nasopharyngeal carcinoma

Alan K S Chiang1, N K Mak2, Wai Tong Ng3

  • 1Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

Oral Oncology
|December 17, 2013
PubMed

Insights

Nasopharyngeal carcinoma (NPC), a viral-driven cancer, often spreads to distant sites despite radiotherapy. Understanding its biology and genetics offers new targeted therapy options for better patient outcomes.

Area of Science:

  • Oncology
  • Virology
  • Genetics

Background:

  • Nasopharyngeal carcinoma (NPC) is a viral-associated malignancy.
  • Current radiotherapy achieves high loco-regional control but fails to prevent distant metastasis.
  • Distant metastasis remains a significant challenge for NPC patients, necessitating effective systemic treatments.

Purpose of the Study:

  • To review recent advancements in understanding NPC biology, including host cell-virus interactions and genetics.
  • To highlight novel therapeutic strategies for treating nasopharyngeal carcinoma.
  • To provide an overview of emerging targeted therapies for NPC.

Main Methods:

  • Literature review of recent research on nasopharyngeal carcinoma.
  • Analysis of studies focusing on tumor biology, viral mechanisms, and genetic profiles in NPC.
  • Synthesis of information on potential targeted therapies.

Main Results:

  • Advances in understanding NPC pathogenesis have identified new therapeutic targets.
  • Host cell-virus interactions and genetic alterations are key areas of investigation.
  • Several novel targeted therapies show promise for NPC treatment.

Conclusions:

  • Targeted therapies based on recent biological and genetic insights offer new hope for managing distant metastasis in NPC.
  • Further research into these novel strategies is crucial for improving patient survival and treatment efficacy.
  • Personalized treatment approaches may be developed based on the specific molecular characteristics of NPC.
Keywords:
AngiogenesisEBVGrowth factor receptorNPCTargeted therapy

More Related Videos

Translational Orthotopic Models of Glioblastoma Multiforme07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.7K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
4.5K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
24.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K